About NeuroVision
NeuroVision is a company based in Sacramento (United States) founded in 2010 by Steven Verdooner. NeuroVision has raised $31.6 million across 8 funding rounds from investors including Johnson & Johnson Innovative Medicine, HHS and Alzheimer's Drug Discovery. The company has 13 employees as of December 31, 2022. NeuroVision offers products and services including BrainHealth.net and Afina™ Retinal Imaging. NeuroVision operates in a competitive market with competitors including Tobii Dynavox, Neurotrack, Artiria, NovaSight and PD Neurotechnology, among others.
- Headquarter Sacramento, United States
- Employees 13 as on 31 Dec, 2022
- Founders Steven Verdooner
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurovision Imaging, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31.6 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
13
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroVision
NeuroVision offers a comprehensive portfolio of products and services, including BrainHealth.net and Afina™ Retinal Imaging.
Platform for screening and managing cognitive health services
AI tool for detecting amyloid in retina related to Alzheimer's
People of NeuroVision
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroVision
NeuroVision has successfully raised a total of $31.6M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NeuroVision
NeuroVision has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovative Medicine, HHS and Alzheimer's Drug Discovery.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funds are managed to support unlisted companies' growth.
|
Locked | Locked | Locked | |
|
Drugs for Alzheimer's prevention, treatment, and cure are discovered.
|
Locked | Locked | Locked | |
|
VSP Vision is engaged in providing comprehensive eye care solutions.
|
Locked | Locked | Locked |
Investor details for NeuroVision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroVision
Investment portfolio details for NeuroVision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuroVision
Detailed financials for NeuroVision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurovision Comparisons
Peer comparison for NeuroVision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuroVision
NeuroVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, Neurotrack, Artiria, NovaSight and PD Neurotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
|
|
| Locked | Locked | Locked |
Neurological disorders are diagnosed using eye-tracking assessment tools.
|
|
| Locked | Locked | Locked |
Micro-navigation systems for stroke surgery are developed.
|
|
| Locked | Locked | Locked |
Eye-tracking solutions for vision assessment and treatment are provided.
|
|
| Locked | Locked | Locked |
A wearable device is developed to monitor Parkinson's movement disorders.
|
|
| Locked | Locked | Locked |
Developer of neurodiagnostic techniques
|
Detailed competitors of NeuroVision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurovision
Complete news archive for NeuroVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroVision
NeuroVision was founded in 2010 and raised its 1st funding round 3 years after it was founded.
NeuroVision is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
Steven Verdooner is the current CEO of NeuroVision. They have also founded this company.
NeuroVision is a funded company, having raised a total of $31.6M across 8 funding rounds to date.
As of Dec 31, 2022, the latest employee count at NeuroVision is 13.
NeuroVision was founded in 2010 in Sacramento, United States, within the neuroscience sector. Diagnostic tests and biomarkers for early detection of amyloid pathology in Alzheimers disease are developed by the company. Retinal imaging technology called Afina is utilized for visualization and measurement of retinal health. Datasets are aggregated, analyzed through biostatistics, and processed with machine learning algorithms to predict neurodegenerative diseases.
NeuroVision's top competitors include NovaSight, iota Biosciences and Tobii Dynavox.
NeuroVision offers BrainHealth.net and Afina™ Retinal Imaging.
NeuroVision has 8 investors. Key investors include Johnson & Johnson Innovative Medicine, HHS, Alzheimer's Drug Discovery, VSP Vision, and Johnson & Johnson Innovation.